Diagnostic Study of Structural Heart Disease Based on Cardiac Electromechanical Signals (NCT07603115) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Diagnostic Study of Structural Heart Disease Based on Cardiac Electromechanical Signals
1,300 participantsStarted 2026-05
Plain-language summary
Study participants will be prospectively recruited from consecutive outpatient and inpatient populations presenting to the Cardiology and Cardiac Surgery Departments of the following participating institutions: The First Affiliated Hospital of Xi'an Jiaotong University, The Second Affiliated Hospital of Xi'an Jiaotong University, and \[add additional participating institutions as applicable\].
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* \- Aged ≥ 18 years.
* For the case group: Presence of valvular lesions confirmed by transthoracic echocardiography.
* For the control group: Normal cardiac valves and no evidence of other cardiovascular diseases confirmed by transthoracic echocardiography.
* Ability to undergo and complete speckle tracking echocardiography.
Exclusion Criteria:
* Patients who are unwilling to participate in this study.
* Patients with a known allergy to the electrode patches or medical adhesive tapes used in this study.
* Patients who are unable to cooperate with the completion of required examinations.
* Patients with incomplete clinical or imaging data that cannot be supplemented.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Diagnostic Accuracy (Sensitivity and Specificity) of the Novel Assay for Valvular Heart Disease
Timeframe: Baseline (At the time of initial diagnostic testing)
Trial details
NCT IDNCT07603115
SponsorFirst Affiliated Hospital Xi'an Jiaotong University